Semler Scientific, Inc.

NasdaqCM:SMLR Stock Report

Market Cap: US$629.3m

Semler Scientific Future Growth

Future criteria checks 0/6

Semler Scientific's revenue is forecast to decline at 24.1% per annum while its annual earnings are expected to grow at 57.2% per year. EPS is expected to grow by 88.3% per annum.

Key information

57.2%

Earnings growth rate

88.28%

EPS growth rate

Medical Equipment earnings growth13.3%
Revenue growth rate-24.1%
Future return on equityn/a
Analyst coverage

Low

Last updated09 Jul 2025

Recent future growth updates

Recent updates

Semler Scientific, Inc.'s (NASDAQ:SMLR) 26% Share Price Surge Not Quite Adding Up

Jul 09
Semler Scientific, Inc.'s (NASDAQ:SMLR) 26% Share Price Surge Not Quite Adding Up

Semler Scientific: Not The Ideal Bitcoin Treasury Company

May 29

Semler Scientific, Inc.'s (NASDAQ:SMLR) 32% Price Boost Is Out Of Tune With Revenues

May 17
Semler Scientific, Inc.'s (NASDAQ:SMLR) 32% Price Boost Is Out Of Tune With Revenues

Here's Why We Think Semler Scientific (NASDAQ:SMLR) Might Deserve Your Attention Today

Mar 25
Here's Why We Think Semler Scientific (NASDAQ:SMLR) Might Deserve Your Attention Today

Semler Scientific's (NASDAQ:SMLR) Profits May Not Reveal Underlying Issues

Mar 07
Semler Scientific's (NASDAQ:SMLR) Profits May Not Reveal Underlying Issues

Semler Scientific, Inc. (NASDAQ:SMLR) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Mar 04
Semler Scientific, Inc. (NASDAQ:SMLR) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Semler Scientific, Inc. (NASDAQ:SMLR) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely

Jan 15
Semler Scientific, Inc. (NASDAQ:SMLR) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely

Semler Scientific: Booking Some Profits After Bitcoin Strategy

Dec 10

Semler Scientific, Inc. (NASDAQ:SMLR) Held Back By Insufficient Growth Even After Shares Climb 27%

Nov 02
Semler Scientific, Inc. (NASDAQ:SMLR) Held Back By Insufficient Growth Even After Shares Climb 27%

Earnings Troubles May Signal Larger Issues for Semler Scientific (NASDAQ:SMLR) Shareholders

Aug 14
Earnings Troubles May Signal Larger Issues for Semler Scientific (NASDAQ:SMLR) Shareholders

The Market Doesn't Like What It Sees From Semler Scientific, Inc.'s (NASDAQ:SMLR) Earnings Yet

Jul 18
The Market Doesn't Like What It Sees From Semler Scientific, Inc.'s (NASDAQ:SMLR) Earnings Yet

We Ran A Stock Scan For Earnings Growth And Semler Scientific (NASDAQ:SMLR) Passed With Ease

May 08
We Ran A Stock Scan For Earnings Growth And Semler Scientific (NASDAQ:SMLR) Passed With Ease

Many Still Looking Away From Semler Scientific, Inc. (NASDAQ:SMLR)

Apr 17
Many Still Looking Away From Semler Scientific, Inc. (NASDAQ:SMLR)

Is Now The Time To Put Semler Scientific (NASDAQ:SMLR) On Your Watchlist?

Jan 11
Is Now The Time To Put Semler Scientific (NASDAQ:SMLR) On Your Watchlist?

Estimating The Intrinsic Value Of Semler Scientific, Inc. (NASDAQ:SMLR)

Dec 07
Estimating The Intrinsic Value Of Semler Scientific, Inc. (NASDAQ:SMLR)

What Does Semler Scientific, Inc.'s (NASDAQ:SMLR) Share Price Indicate?

Apr 07
What Does Semler Scientific, Inc.'s (NASDAQ:SMLR) Share Price Indicate?

Calculating The Intrinsic Value Of Semler Scientific, Inc. (NASDAQ:SMLR)

Dec 14
Calculating The Intrinsic Value Of Semler Scientific, Inc. (NASDAQ:SMLR)

Semler Scientific: Growth, Profits, And Valuation Models Support A Buy

Aug 02

Semler Scientific: A Small Company Solving A Big Problem

Apr 21

Things Look Grim For Semler Scientific, Inc. (NASDAQ:SMLR) After Today's Downgrade

Mar 08
Things Look Grim For Semler Scientific, Inc. (NASDAQ:SMLR) After Today's Downgrade

Earnings and Revenue Growth Forecasts

NasdaqCM:SMLR - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202632-7N/A-172
12/31/202533-36N/A-52
3/31/202549-301717N/A
12/31/202456412424N/A
9/30/20245916-4721N/A
6/30/20246216-4020N/A
3/31/202466222626N/A
12/31/202368212121N/A
9/30/202367201719N/A
6/30/202365182022N/A
3/31/202361161417N/A
12/31/202257141517N/A
9/30/202254131617N/A
6/30/202254131617N/A
3/31/202254161213N/A
12/31/202153171516N/A
9/30/202154211920N/A
6/30/202150221516N/A
3/31/202142161516N/A
12/31/202039141415N/A
9/30/202036111213N/A
6/30/202034141314N/A
3/31/202035161315N/A
12/31/201933151113N/A
9/30/201930141011N/A
6/30/201926768N/A
3/31/201924667N/A
12/31/2018215N/A5N/A
9/30/2018204N/A3N/A
6/30/2018182N/A2N/A
3/31/2018150N/A1N/A
12/31/201712-2N/A1N/A
9/30/201711-2N/A0N/A
6/30/20179-2N/A0N/A
3/31/20178-2N/A-1N/A
12/31/20167-3N/A-2N/A
9/30/20168-7N/A-4N/A
6/30/20167-8N/A-3N/A
3/31/20167-8N/A-4N/A
12/31/20157-9N/A-4N/A
9/30/20155-5N/A-4N/A
6/30/20154-5N/A-4N/A
3/31/20154-5N/A-4N/A
12/31/20144-5N/A-4N/A
9/30/20143-4N/A-3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SMLR is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: SMLR is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: SMLR is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: SMLR's revenue is expected to decline over the next 3 years (-24.1% per year).

High Growth Revenue: SMLR's revenue is forecast to decline over the next 3 years (-24.1% per year).

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if SMLR's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/11 00:04
End of Day Share Price 2025/07/11 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Semler Scientific, Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mark PalmerBenchmark Company
Marc WiesenbergerB. Riley Securities, Inc.
Matthew GalinkoMaxim Group